Ridgewood Investments’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303K | Sell |
8,412
-11,236
| -57% | -$405K | 0.13% | 165 |
|
|
2025
Q1 | $612K | Sell |
19,648
-11,087
| -36% | -$345K | 0.29% | 99 |
|
|
2024
Q4 | $784K | Buy |
30,735
+8,913
| +41% | +$227K | 0.38% | 81 |
|
|
2024
Q3 | $617K | Sell |
21,822
-2,620
| -11% | -$74.1K | 0.31% | 94 |
|
|
2024
Q2 | $645K | Sell |
24,442
-602
| -2% | -$15.9K | 0.32% | 94 |
|
|
2024
Q1 | $761K | Buy |
25,044
+120
| +0.5% | +$3.64K | 0.4% | 78 |
|
|
2023
Q4 | $700K | Sell |
24,924
-863
| -3% | -$24.2K | 0.41% | 84 |
|
|
2023
Q3 | $700K | Buy |
25,787
+4,267
| +20% | +$116K | 0.46% | 75 |
|
|
2023
Q2 | $662K | Buy |
21,520
+14,175
| +193% | +$436K | 0.38% | 79 |
|
|
2023
Q1 | $265K | Buy |
7,345
+1,975
| +37% | +$71.2K | 0.16% | 146 |
|
|
2022
Q4 | $212K | Sell |
5,370
-302
| -5% | -$11.9K | 0.15% | 171 |
|
|
2022
Q3 | $228K | Sell |
5,672
-276
| -5% | -$11.1K | 0.19% | 151 |
|
|
2022
Q2 | $250K | Sell |
5,948
-12,852
| -68% | -$540K | 0.2% | 149 |
|
|
2022
Q1 | $732K | Sell |
18,800
-249
| -1% | -$9.7K | 0.48% | 69 |
|
|
2021
Q4 | $759K | Buy |
19,049
+543
| +3% | +$21.6K | 0.48% | 73 |
|
|
2021
Q3 | $669K | Buy |
18,506
+2,860
| +18% | +$103K | 0.45% | 74 |
|
|
2021
Q2 | $641K | Buy |
15,646
+10,223
| +189% | +$419K | 0.41% | 88 |
|
|
2021
Q1 | $237K | Buy |
+5,423
| New | +$237K | 0.15% | 168 |
|